Report 48: The Value of Vaccine Booster Doses to Mitigate the Global Impact of the Omicron SARS-CoV-2 Variant.; 2021:1-38. doi:10.25561/93034 (2021)

First Author: Hogan A
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Technical Report